| Title : What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink - Walker_2018_Alzheimers.Res.Ther_10_51 |
| Author(s) : Walker VM , Davies NM , Kehoe PG , Martin RM |
| Ref : Alzheimers Res Ther , 10 :51 , 2018 |
| Abstract : |
| PubMedSearch : Walker_2018_Alzheimers.Res.Ther_10_51 |
| PubMedID: 29843807 |
| Title : What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink - Walker_2018_Alzheimers.Res.Ther_10_51 |
| Author(s) : Walker VM , Davies NM , Kehoe PG , Martin RM |
| Ref : Alzheimers Res Ther , 10 :51 , 2018 |
| Abstract : |
| PubMedSearch : Walker_2018_Alzheimers.Res.Ther_10_51 |
| PubMedID: 29843807 |
| Title : What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink - Walker_2018_Alzheimers.Res.Ther_10_51 |
| Author(s) : Walker VM , Davies NM , Kehoe PG , Martin RM |
| Ref : Alzheimers Res Ther , 10 :51 , 2018 |
| Abstract : |
| PubMedSearch : Walker_2018_Alzheimers.Res.Ther_10_51 |
| PubMedID: 29843807 |